- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05080062
Requirements and Functional Schedule as a Part of Painrehabilitation.
Requirements and Functional Schedule- An Intervention to Use in Painrehabilitation, to Strengthen the Collaboration Between the Healthcare, Employers and Employees
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Description of the intervention: Demand and Ability Protocol Demand and Ability Protocol (DAP) is an intervention linked to the International Classification of Functioning, Disability and Health, and is based on the Dutch Functional Ability List and knowledge about disability in working life (Brouwer et al, 2002). The intervention has been further developed and modified in Norway and is primarily used in occupational health care services for collaboration between an employee and his or her immediate manager (Engbers & Furuland, 2006).
The intervention consists of a structured conversation between the patient and his immediate manager under the guidance of licensed medical staff (in this case REKO) with knowledge of the requirements of the patient's work and his/her current functional ability. The intervention takes about 90 minutes excluding preparation time for REKO.
DAP consider the following domains; 1) mental and cognitive ability, 2) basic skills and social ability, 3) tolerance for physical conditions, 4) ability to work dynamically, 5) ability to work statically and 6) to be able to work certain times.
Based on the above domains, a structured review is made of the balance between requirements and function in current work in order to identify possible adaptations and measures at the workplace. During the intervention, the work requirements and the patient's function/ability are identified on a three-point scale and in domains where the rating of requirements and function/ability does not match, there is thus an imbalance, and here adjustments or changed tasks may be relevant to consider increasing work ability and reducing sick leave. The intervention concludes with a summary of the situation and joint development of appropriate measures/adaptations to promote the patient's RTW. This is documented on a form, which is signed by both the patient and the manage
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Katarina Danielsson, MD
- Telefonnummer: 000186110000 000186110000
- E-post: katarina.danielsson@akademiska.se
Studer Kontakt Backup
- Navn: Katarina Danielsson
- Telefonnummer: 000186110000 000186110000
- E-post: katarina.danielsson@akademiska.se
Studiesteder
-
-
-
Uppsala, Sverige, 75239
- Rekruttering
- Katarina Danielsson
-
Ta kontakt med:
- Katarina Danielsson
- Telefonnummer: 000186110000 000186110000
- E-post: katarina.danielsson@akademiska.se
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Chronic pain, has an employment
Exclusion Criteria:
no longer than 6 month of total sick-leave
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Painrehabilitation + Demand and ability protocol
Will receive pain-rehabilitation and the intervention ( an interview called Requirements and functional Schedule, with the patients employer and an occupational therapist)
|
An interview with the employee and the employer where the occupational worker is leading the interview and a pain rehabilitation-program
|
Aktiv komparator: Painrehabilitation
Will receive pain-rehabilitation
|
a pain rehabilitation-program
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Absence from work (sickleave) measured with a question to the participants
Tidsramme: Changes from baseline in absence from work to the end of the rehab program (average 4month)
|
Less absence from work
|
Changes from baseline in absence from work to the end of the rehab program (average 4month)
|
Absence from work (sickleave) measured with a question to the participants
Tidsramme: Changes from baseline in absence from work through study completion (average 1,5 years)
|
Less absence from work
|
Changes from baseline in absence from work through study completion (average 1,5 years)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Changes in EuroQol 5-dimensions questionnaire (EQ-5D)
Tidsramme: Change from baseline in EuroQol 5-dimensions through study completion (average 1,5 years)
|
Changes in quality of Life measured with the EuroQol 5-dimensions. Each combination of values has an idex value where 1 is the best quality of life. The questionnaire also includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, with higher scores for higher qulaity of life . |
Change from baseline in EuroQol 5-dimensions through study completion (average 1,5 years)
|
Changes in EuroQol 5-dimensions
Tidsramme: Change from baseline in EuroQol 5-dimensions to the end of the rehab program (average foru month)
|
Changes in quality of Life measured with the EuroQol 5-dimensions.
Each combination of values has an idex value where 1 is the best quality of life.
The questionnaire also includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, with higher scores for higher qulaity of life
|
Change from baseline in EuroQol 5-dimensions to the end of the rehab program (average foru month)
|
Changes in Anxiety and depression
Tidsramme: Change from baseline in anxiety and depression through study completion (average 1,5 years)hs)
|
Changes in Hospital Anxiety and Depression Scale (HADS).
The scale icludes two subscales one focusing on anxiety symptoms and one on depressive symptoms.
The minimum value is 0 and the maximum value is 21 for each subscale.
Higher scores means worse outcome.
|
Change from baseline in anxiety and depression through study completion (average 1,5 years)hs)
|
Changes in Anxiety and depression
Tidsramme: Change from baseline in anxiety and depression to the end of the rehab program (average four month)
|
Changes in Hospital Anxiety and Depression Scale (HADS).
The scale icludes two subscales one focusing on anxiety symptoms and one on depressive symptoms.
The minimum value is 0 and the maximum value is 21 for each subscale.
Higher scores means worse outcome.
|
Change from baseline in anxiety and depression to the end of the rehab program (average four month)
|
Changes in sleep
Tidsramme: Change from baseline in Insomnia Severity Index to the end of the rehab program (average four month)
|
Changes in Insomnia measured with Insomnia Severity Index (ISI).
The minimum value is 0 and the maximum value is 28.
Higher scores indicates a worse outcome.
|
Change from baseline in Insomnia Severity Index to the end of the rehab program (average four month)
|
Changes in sleep
Tidsramme: Change from baseline in Insomnia Severity Index through study completion (average 1,5 years)
|
Changes in sleep measured with Insomnia Severity Index (ISI).
The minimum value is 0 and the maximum value is 28.
Higher scores indicates a worse outcome.
|
Change from baseline in Insomnia Severity Index through study completion (average 1,5 years)
|
Changes in Life satisfaction
Tidsramme: Change from baseline in Life Satisfaction Questionnaire to the end of the rehab program (average four month)
|
Changes in Life Satisfaction measured with Life Satisfaction Questionnaire (Li-Sat-11).
Minimum score at 11 and maximum score at 66. Higher scores indicate a greater level of perceived satisfaction.
|
Change from baseline in Life Satisfaction Questionnaire to the end of the rehab program (average four month)
|
Changes in Life satisfaction
Tidsramme: Change from baseline in Life Satisfaction Questionnaire through study completion (average 1,5 years)
|
Changes in Life Satisfaction measured with Life Satisfaction Questionnaire (Li-Sat-11).
Minimum score at 11 and maximum score at 66. Higher scores indicate a greater level of perceived satisfaction.
|
Change from baseline in Life Satisfaction Questionnaire through study completion (average 1,5 years)
|
Changes in Work ability
Tidsramme: Change from baseline in Work ability to the end of the rehab program (average four month)
|
Changes in work ability measured with the 7:th question in Work Ability Index questionnaire
|
Change from baseline in Work ability to the end of the rehab program (average four month)
|
Changes in Work ability
Tidsramme: Change from baseline in Work ability through study completion (average 1,5 years)
|
Changes in work ability measured with the 7:th question in Work Ability Index questionnaire
|
Change from baseline in Work ability through study completion (average 1,5 years)
|
Changes in health-related quality of life
Tidsramme: Change from baseline in RAND-36 to the end of the rehab program (average four month)
|
Changes in health-related quality of life measured with RAND-36.
The RAND-36 consists of 36 items grouped into eight multi-item scales: physical functioning (PF), role-functioning/physical (RP), pain (P), general health (GH), energy/fatigue (EF), social functioning (SF), role-functioning/emotional (RE), and emotional well-being (EW).
An additional item asks about health change (HC) in the past year.
Scale scores are summed and transformed into scales ranging from 0 (worst possible health state) to 100 (best possible state).
|
Change from baseline in RAND-36 to the end of the rehab program (average four month)
|
Changes in health-related quality of life
Tidsramme: Change from baseline in RAND-36 through study completion (average 1,5 years)
|
Changes in health-related quality of life measured with RAND-36.
The RAND-36 consists of 36 items grouped into eight multi-item scales: physical functioning (PF), role-functioning/physical (RP), pain (P), general health (GH), energy/fatigue (EF), social functioning (SF), role-functioning/emotional (RE), and emotional well-being (EW).
An additional item asks about health change (HC) in the past year.
Scale scores are summed and transformed into scales ranging from 0 (worst possible health state) to 100 (best possible state).
|
Change from baseline in RAND-36 through study completion (average 1,5 years)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Therese Hellman, PhD, Uppsala University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2019/01755
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kronisk smerte
-
Clínica de Oftalmología de Cali S.AFullførtMeibomian kjerteldysfunksjon | Eyes Dry ChronicColombia
-
Alcon ResearchFullført
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRekrutteringRefractory Chronic Graft Versus Host Disease (cGVHD)Belgia
-
East Carolina UniversityTilbaketrukket
-
Wake Forest University Health SciencesRekruttering
-
Cairo UniversityFullførtCervical Myofascial Pain SyndromeEgypt
-
Dilşad SindelFullførtKvinnelige pasienter med Myofascial Pain Syndrome (MPS) relatert til øvre Trapezius Active Trigger Points (TP)
-
Brugmann University HospitalTilbaketrukketPhantom Limb Pain (PLP) | Primær/sekundær arrhyperalgesiBelgia
-
Oslo University HospitalUniversity of Oslo; Fysiofondet; Oslo Metropolitan UniversityRekrutteringGluteal tendinopati | Trochanterisk bursitt | Lateral hoftesmerter | GTPS - Greater Trochanteric Pain SyndromeNorge
-
Occyo GmbHUniversity Clinic for Ophthalmology and Optometry- SalzburgFullførtLimbal stamcelle mangel | Hornhinnesykdom | Eyes Dry Chronic | Kronisk konjunktivitt i begge øyne | Øyelesjon | Øyesykdom; Grå stær | Øyne Tørr følelse av | Hornhinne betent | Hornhinne; Skade, slitasje | HornhinneinfeksjonØsterrike
Kliniske studier på Requirements and functional Schedule
-
Gazi UniversityFullførtMultippel sklerose, tilbakefallende-remitterendeTyrkia
-
Nantes University HospitalFondation de France; Nantes UniversitéRekrutteringBeskrivende | Palliativ omsorg | OnkologiFrankrike